[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Povidone Iodine: 2% Povidone Iodine gargle diluted to 1% (w/v) is used as oropharyngeal gargle and intranasal application given 4 times to 48 laboratory tested COVID-19 patients and followed up for 12 weeksControl Intervention1: normal saline: 48 patients laboratory tested COVID-19 positive selected and tested on 7th and 21st day for comparison and followed for 12 weeks to check for any relapse", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Povidone Iodine: 2% Povidone Iodine gargle diluted to 1% (w/v) is used as oropharyngeal gargle and intranasal application given 4 times to 48 laboratory tested COVID-19 patients and followed up for 12 weeks", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: normal saline: 48 patients laboratory tested COVID-19 positive selected and tested on 7th and 21st day for comparison and followed for 12 weeks to check for any relapse", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "Used as oropharyngeal gargle and intranasal application", "treatment_id": 1015, "treatment_name": "Povidone-iodine", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Povidone Iodine: 2% Povidone Iodine gargle diluted to 1% (w/v) is used as oropharyngeal gargle and intranasal application given 4 times to 48 laboratory tested COVID-19 patients and followed up for 12 weeksControl Intervention1: normal saline: 48 patients laboratory tested COVID-19 positive selected and tested on 7th and 21st day for comparison and followed for 12 weeks to check for any relapse", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Povidone Iodine: 2% Povidone Iodine gargle diluted to 1% (w/v) is used as oropharyngeal gargle and intranasal application given 4 times to 48 laboratory tested COVID-19 patients and followed up for 12 weeks", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: normal saline: 48 patients laboratory tested COVID-19 positive selected and tested on 7th and 21st day for comparison and followed for 12 weeks to check for any relapse", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]